Skip to content
Screener

Halozyme Therapeutics HALO Impact to revenue from performance obligations satisfied (or partially satisfied) in previous periods

Impact to revenue from performance obligations satisfied (or partially satisfied) in previous periods at other companies

Willis Towers Watson logo
Willis Towers WatsonWTW
$0—
FTI Consulting logo
FTI ConsultingFCN
$15.1M+11.9%
Vertex, Inc. logo
Vertex, Inc.VERX
$84.83M+17.0%
Kyndryl Holdings logo
Kyndryl HoldingsKD
$2M-84.6%
Adeia logo
AdeiaADEA
$22.23M+4,319%
Bit Digital logo
Bit DigitalBTBT
$5.1M+155%

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$9.91B+36.0%
Enterprise value$11.93B+36.1%
P/E13.8×-3.9×
P/S6×-0.2×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×